Shuttle Pharmaceuticals HoldSHPH
13F holders, Q2 2026 (June 30)5holders
1famous investor
$3.25avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Shuttle Pharmaceuticals Hold (SHPH) in their 13F filings. The largest holders were HRT Financial LP ($255K), Citadel Advisors ($79K) and Barclays PLC ($2K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Shuttle Pharmaceuticals Hold
- CUSIP
- 825693500
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $338K |
| Exits | 0 | $0 |
Ownership 5 holders
| HRT Financial LP | 0.00% | New | 78,597 | $255K |
| Citadel Advisors | 0.00% | New | 24,354 | $79K |
| Barclays PLC | 0.00% | New | 750 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 389 | $1K |
| Kelleher Financial Advisors | 0.00% | New | 120 | $390 |
"% of holder's portfolio" is SHPH's weight in each manager's 13F, not the share of Shuttle Pharmaceuticals Hold the manager owns.